Chun‐wa Chung

12.0k total citations · 1 hit paper
76 papers, 4.3k citations indexed

About

Chun‐wa Chung is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Chun‐wa Chung has authored 76 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 22 papers in Hematology and 11 papers in Oncology. Recurrent topics in Chun‐wa Chung's work include Protein Degradation and Inhibitors (40 papers), Multiple Myeloma Research and Treatments (22 papers) and Ubiquitin and proteasome pathways (21 papers). Chun‐wa Chung is often cited by papers focused on Protein Degradation and Inhibitors (40 papers), Multiple Myeloma Research and Treatments (22 papers) and Ubiquitin and proteasome pathways (21 papers). Chun‐wa Chung collaborates with scholars based in United Kingdom, United States and Germany. Chun‐wa Chung's co-authors include Rab K. Prinjha, Paul Bamborough, Uwe Schaefer, Alexander Tarakhovsky, Edwige Nicodème, Rohit Chandwani, Kate L. Jeffrey, Jorge Kirilovsky, Julia H. White and Charles M. Rice and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Chun‐wa Chung

76 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Suppression of inflammation by a synthetic histone mimic

2010 1.2k citations Chun‐wa Chung, Rab K. Prinjha et al. profile →

Peers

Countries citing papers authored by Chun‐wa Chung

Since Specialization

Citations

This map shows the geographic impact of Chun‐wa Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun‐wa Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun‐wa Chung more than expected).

Fields of papers citing papers by Chun‐wa Chung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun‐wa Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun‐wa Chung. The network helps show where Chun‐wa Chung may publish in the future.

Co-authorship network of co-authors of Chun‐wa Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Chun‐wa Chung. A scholar is included among the top collaborators of Chun‐wa Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun‐wa Chung. Chun‐wa Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The 17^th EFMC Short Course on Medicinal Chemistry on Small Molecule Protein Degraders 2023 ·ChemMedChem ·Alessio Ciulli, (unknown), Chun‐wa Chung, Ingo V. Hartung, Andrea Testa, Danette L. Daniels, Laura H. Heitman	7
2	Structure-Guided Design of a Domain-Selective Bromodomain and Extra Terminal N-Terminal Bromodomain Chemical Probe 2023 ·Journal of Medicinal Chemistry ·Erin K. Bradley, (unknown), Chun‐wa Chung, Peter D. Craggs, Emmanuel H. Demont, P. G. Humphreys, Darren J. Mitchell, (unknown), Inmaculada Rioja, (unknown), Christopher R. Wellaway, Rab K. Prinjha, David Scott Palmer, William J. Kerr, Marc Reid, Ian D. Wall, (unknown)	6
3	Empirical Bayes functional models for hydrogen deuterium exchange mass spectrometry 2022 ·Communications Biology ·Oliver M. Crook, Chun‐wa Chung, Charlotte M. Deane	5
4	Discovery and Characterisation of Highly Cooperative FAK‐Degrading PROTACs 2021 ·Angewandte Chemie International Edition ·Robert P. Law, João Nunes, Chun‐wa Chung, Marcus Bantscheff, (unknown), Han Dai, John P. Evans, (unknown), (unknown), Antonia J. Lewis, Marcel Muelbaier, Paul Scott‐Stevens, Peter Stacey, (unknown), Gillian F. Watt, Nico Zinn, Markus A. Queisser, John D. Harling, Andrew B. Benowitz	85
5	Discovery and Characterisation of Highly Cooperative FAK‐Degrading PROTACs 2021 ·Angewandte Chemie ·Robert P. Law, João Nunes, Chun‐wa Chung, Marcus Bantscheff, (unknown), Han Dai, John P. Evans, (unknown), (unknown), Antonia J. Lewis, Marcel Muelbaier, Paul Scott‐Stevens, Peter Stacey, (unknown), Gillian F. Watt, Nico Zinn, Markus A. Queisser, John D. Harling, Andrew B. Benowitz	4
6	Cycloalkane-modified amphiphilic polymers provide direct extraction of membrane proteins for CryoEM analysis 2021 ·Communications Biology ·A.J. Higgins, (unknown), (unknown), (unknown), Vincent L. G. Postis, Jonathan D. Lippiat, Chun‐wa Chung, Tom Ceska, Manuela Zoonens, Frank Sobott, Stephen P. Muench	18
7	Structural Insights into PROTAC-Mediated Degradation of Bcl-xL 2020 ·ACS Chemical Biology ·Chun‐wa Chung, Han Dai, Esther Fernández, Christopher P. Tinworth, Ian Churcher, Jenni Cryan, Jane Denyer, John D. Harling, Agnieszka Konopacka, Markus A. Queisser, (unknown), Gillian F. Watt, Fan Jiang, Dongming Qian, Andrew B. Benowitz	67
8	Cryo-EM in drug discovery 2019 ·Biochemical Society Transactions ·Tom Ceska, Chun‐wa Chung, (unknown), Chris Phillips, Pamela A. Williams	32
9	Identification of Selective Inhibitors of Plasmodium N-Myristoyltransferase by High-Throughput Screening 2019 ·Journal of Medicinal Chemistry ·Anke Harupa, (unknown), Gonzalo Colmenarejo, (unknown), (unknown), (unknown), Chun‐wa Chung, (unknown), Peter J. Myler, (unknown), Félix Calderón, (unknown), (unknown), (unknown), (unknown), Bart L. Staker, (unknown), Alexis Kaushansky	17
10	Structure-Guided Identification of Resistance Breaking Antimalarial N‑Myristoyltransferase Inhibitors 2019 ·Cell chemical biology ·Anja Schlott, Stephen J. Mayclin, (unknown), Olivia Coburn‐Flynn, Andrew Bell, Judith L. Green, Ellen Knuepfer, (unknown), Roger V. Bonnert, Brice Campo, Jeremy N. Burrows, (unknown), Bart L. Staker, Chun‐wa Chung, Peter J. Myler, David A. Fidock, Edward W. Tate, Anthony A. Holder	24
11	Single-Domain Antibodies as Crystallization Chaperones to Enable Structure-Based Inhibitor Development for RBR E3 Ubiquitin Ligases 2019 ·Cell chemical biology ·(unknown), Henrik Johansson, David P. Dixon, Stephen R. Martin, Chun‐wa Chung, (unknown), David House, Katrin Rittinger	12
12	Screening of a Novel Fragment Library with Functional Complexity against Mycobacterium tuberculosis InhA 2018 ·ChemMedChem ·Federica Prati, Fabio Zuccotto, Daniel A. Fletcher, M.A. Convery, (unknown), Robert H. Bates, Lourdes Encinas, Jingkun Zeng, Chun‐wa Chung, (unknown), (unknown), Claire J. Mackenzie, Simon R. Green, (unknown), David Barros, Paul G. Wyatt, Peter C. Ray	14
13	Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1 2018 ·Scientific Reports ·(unknown), (unknown), Ute Möllmann, Kerstin Voigt, Chun‐wa Chung, Onkar Singh, Michael Rees, Alfonso Mendoza-Losana, Robert H. Bates, Lluís Ballell, Sarah M. Batt, Natacha Veerapen, Klaus Fütterer, Gurdyal S. Besra, Peter Imming, Argyrides Argyrou	45
14	Structural and Functional Basis of C-Methylation of Coumarin Scaffolds by NovO 2017 ·ACS Chemical Biology ·(unknown), Chun‐wa Chung, J. Mosley, Glenn A. Burley, Luke Humphreys	23
15	Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase 2017 ·Nature Communications ·Jonathan P. Hutchinson, Paul Rowland, (unknown), (unknown), Carl Haslam, Clare I. Hobbs, Duncan S. Holmes, Paul Homes, John Liddle, Damian J. Mole, Iain Uings, Ann L. Walker, Scott P. Webster, Christopher G. Mowat, Chun‐wa Chung	37
16	New direct inhibitors of InhA with antimycobacterial activity based on a tetrahydropyran scaffold 2016 ·European Journal of Medicinal Chemistry ·Stane Pajk, (unknown), Roman Šink, Izidor Sosič, Margarete Neu, Chun‐wa Chung, María Martínez-Hoyos, Esther Pérez‐Herrán, Daniel Álvarez-Gómez, Emilio Álvarez-Ruíz, Alfonso Mendoza-Losana, Julia Castro‐Pichel, David Barros, Lluís Ballell, Robert J. Young, M.A. Convery, Lourdes Encinas, Stanislav Gobec	25
17	1,3-Dimethyl Benzimidazolones Are Potent, Selective Inhibitors of the BRPF1 Bromodomain 2014 ·ACS Medicinal Chemistry Letters ·Emmanuel H. Demont, Paul Bamborough, Chun‐wa Chung, Peter D. Craggs, David J. Fallon, Laurie Gordon, Paola Grandi, Clare I. Hobbs, (unknown), Emma J. Jones, Armelle Le Gall, Anne‐Marie Michon, Darren J. Mitchell, Rab K. Prinjha, Andy D. Roberts, Robert J. Sheppard, Robert J. Watson	68
18	Small Molecule Bromodomain Inhibitors 2012 ·Progress in medicinal chemistry ·Chun‐wa Chung	37
19	Over Expression of Wild Type or a Catalytically Dead Mutant of SIRTUIN 6 Does Not Influence NFκB Responses 2012 ·PLoS ONE ·Rachel L. Grimley, Oxana Polyakova, Jessica Vamathevan, (unknown), Brian Hayes, Champa Patel, Janet L. Smith, Angela Bridges, Andrew Fosberry, (unknown), (unknown), Chun‐wa Chung, (unknown), Nicola J. Richmond, (unknown), Roberto Solari	26
20	The use of biophysical methods increases success in obtaining liganded crystal structures 2006 ·Acta Crystallographica Section D Biological Crystallography ·Chun‐wa Chung	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact